NASDAQ: NARI
Last close prices updated as of
Jun 09, 2023, 4:00 PM EST
| USD | BATS BZX Real-Time Price
- Last Close 60.09
- Sector Healthcare
- Industry Medical Devices
- Investment Style Small Growth
- Day Range 60.05 – 60.85
- Year Range 52.59 – 86.94
- Market Cap 3.4355 Bil
- Volume / Avg 440,513.0 / 801,093.8
- Price / Sales 7.83
- Price / Book 8.05
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis NARI
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
About Quantitative Ratings
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Unlock Our Full Analysis With Morningstar Investor
Company Profile NARI
Business Description
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism. The company generates revenue from the sale of ClotTriever and FlowTriever systems directly to hospitals located in the United States. Majority of revenue is generated from FlowTriever system.
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Inari Medical Inc Ordinary Shares
XNAS: NARI
| Pulmonx Corp Ordinary Shares
XNAS: LUNG
| ShockWave Medical Inc
XNAS: SWAV
| Neovasc Inc
XTSE: NVCN
| |
Price
| 60.09 | 12.55 | 290.48 | — |
Currency
| USD | USD | USD | — |
Change
| −$0.03 (0.05%) | +$0.36 (2.95%) | +$2.16 (0.75%) | — |
Market Cap
| 3.44 Bil | 473.74 Mil | 10.64 Bil | — |
Industry
| Medical Devices | Medical Devices | Medical Devices | Medical Devices |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Inari Medical Inc Ordinary Shares Stock
No. NARI does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
NARI’s market cap is 3.44 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
NARI’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
NARI’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare NARI’s historical performance against its industry peers and the overall market.